Volume 26, Issue 3 - Observational Studies

Registration and ethics committee approval for observational studies: Current status and way forward

Authors: Namrata Singh, Vasudha

Abstract

Download the full article

References

1. Song JW, Chung KC. Observational studies: cohort and case-control studies. Plast Reconstr Surg 2010;126:2234-42. Available from: http://
2. Silverman SL. From randomized controlled trials to observational studies. Am J Med 2009;122:114-20. Available from: http://
3. Mariani AW, Pêgo-Fernandes PM. Observational studies: why are they so important? Sao Paulo Med J 2014;132:1-2. Available from: http://
4. Schillaci G, Battista F, Pucci G. Are observ - ational studies more informative than randomized controlled trials in hypertension? Con side of the argu ment. Hypertension 2013;62:470-6. Available from: http://
5. Benson K, Hartz AJ. A comparison of observational studies and randomised, controlled trials. N Engl J Med 2000;342:1878-86. Available from: http://
6. Concato J, Shah N, Horwitz RI. Randomized, controlled trials, observational studies, and the hierarchy of research designs. N Engl J Med 2000;342:1887-92. Available from: http://
7. Grant WB. Using findings from observational studies to guide vitamin D randomized controlled trials. J Intern Med 2015;277:83-6. Available from: http://
8. Faraoni D, Schaefer ST. Randomized controlled trials vs. observational studies: why not just live together? BMC Anesthesiol 2016;16:102. Available from: http://
9. Hannan EL. Randomized clinical trials and observational studies: guidelines for assessing respective strengths and limitations. JACC Cardiovasc Interv 2008;1:211-7. Available from: http://
10. FDA. Early Communication about an Ongoing Safety Review of Ziagen (Abacavir) and Videx (Didanosine). 2017 [cited 2017 June 07]. Available from: Available from: https://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/DrugSafetyInformationforHeathcareProfessionals/ucm070263
11. Morton SC, Costlow MR, Graff JS, Dubois RW. Standards and guidelines for observational studies: quality is in the eye of the beholder. J Clin Epidemiol 2016;71:3-10. Available from: http://
12. AHRQ Methods for Effective Health Care. Velentgas P, Dreyer NA, Nourjah P, Smith SR, Torchia MM, editors. Developing a Protocol for Observational Comparative Effectiveness Research: A User’s Guide. Rockville (MD): Agency for Healthcare Research and Quality (US); 2013 [cited 2017 June 07]. Available from: Available from: https://www.ncbi.nlm.nih.gov/pubmed/23469377
13. Berger ML, Martin BC, Husereau D et al. A questionnaire to assess the relevance and credibility of observational studies to inform health care decision making: an ISPOR-AMCP-NPC good practice task force report. Value Health 2014;17:143-56. Available from: http://
14. The European Network of Centres for Pharmacoepidemiology and Pharma - covigilance (ENCePP). ENCePP Checklist for study protocols (revision 3). 2017 [cited 2017 June 07]. Available from: Available from: http://www.encepp.eu/encepp/openAttachment/methodologicalDeclaration/19034;jsessionid=8FX83-nDtJBQU68dzHjDZj-TG4Z_eH1Qto6W0iqP5tEamNws3gbL!298584184
15. The European Network of Centres for Pharmacoepidemiology and Pharma - covigilance (ENCePP). Guide on Methodological Standards in Pharma - coepidemiology (revision 5). 2017 [cited 2017 June 07]. Available from: Available from: http://www.encepp.eu/standards_and_guidances/documents/ENCePPGuideofMethStandardsinPE_Rev5.pdf
16. U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER), Center for Biologics Evaluation and Research (CBER). Guidance for industry: good pharmacovigilance practices and pharmacoepidemiologic assessment. 2007 [cited 2017 June 07]. Available from: Available from: https://www.fda.gov/downloads/regulatoryinformation/guidances/ucm126834.pdf
17. Dreyer NA, Velentgas P, Westrich K, Dubois R. The GRACE checklist for rating the quality of observational studies of comparative effectiveness: a tale of hope and caution. J Manag Care Spec Pharm 2014;20:301-8. Available from: http://
18. The GRACE Initiative. GRACE principles: Good ReseArch for Comparative Effectiveness. 2017 [cited 2017 June 07]. Available from: Available from: https://www.pharmacoepi.org/pub/1c29f69f-2354-d714-5100-1ef2b0e9abd9
19. Berger ML, Mamdani M, Atkins D, Johnson ML. Good research practices for comparative effectiveness research: defining, reporting and interpreting nonrandomised studies of treatment effects using secondary data sources: the ISPOR Good Research Practices for Retrospective Database Analysis Task Force Report – Part I. Value Health 2009;12:1044-52. Available from: http://
20. Patient-Centered Outcomes Research Institute (PCORI). PCORI Methodology Standards. 2017 [cited 2017 June 07]. Available from: Available from: http://www.pcori.org/research-results/about-our-research/research-methodology/pcorimethodology-standards
21. World Medical Association. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA 2013;310:2191-4. Available from: http://
22. Loder E, Groves T, MacAuley D. Registration of observational studies. BMJ. 2010;340(2):c950.
23. ClinicalTrials.gov. FDAAA 801 Requirements. 2017 [cited 2017 June 07]. Available from: Available from: https://clinicaltrials.gov/ct2/manage-recs/fdaaa
24. Williams RJ, Tse T, Harlan WR, Zarin DA. Registration of observational studies: is it time? CMAJ 2010;182:1638-42. Available from: http://
25. ClinicalTrials.gov. ClinicalTrials.gov Protocol Registration Data Element Definitions for Interventional and Observational Studies. 2017 [cited 2017 June 07]. Available from: Available from: https://prsinfo.clinicaltrials.gov/definitions.html
26. The European Network of Centres for Pharmacoepidemiology and Pharma - covigilance (ENCePP). The European Union electronic Register of Post- Authorisation Studies (EU PAS Register). 2017 [cited 2017 June 07]. Available from: Available from: http://www.encepp.eu/encepp_studies/indexRegister.shtml
27. Boccia S, Rothman KJ, Panic N et al. Registration practices for observational studies on ClinicalTrials.gov indicated low adherence. J Clin Epidemiol 2016;70: 176-82. Available from: http://
28. Rasmussen LS, Gisvold SE, Wisborg T. Ethics Committee approval for observational studies. Acta Anaesthesiol Scand 2014;58:1047-8. Available from: http://
29. Perlman M. Ethical issues in ‘observational research’. Paediatr Child Health 2000;5:89- 90. Available from: http://
30. Kıraç FS. Is Ethics Approval Necessary for all Trials? A Clear But Not Certain Process. Mol Imaging Radionucl Ther. 2013;22(3):73-5. Available from: http://
31. Orchard J. For debate: should observational clinical studies require ethics committee approval? J Sci Med Sport 2008;11:239-42. Available from: http://
32. Moser B, Röggla G. Should observational clinical studies require ethics committee approval? J Sci Med Sport 2008;11:518. Available from: http://
33. Claudot F, Alla F, Fresson J, Calvez T, Coudane H, Bonaïti-Pellié C. Ethics and observational studies in medical research: various rules in a common framework. Int J Epidemiol 2009;38:1104-8. Available from: http://
34. von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP; STROBE Initiative. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Ann Intern Med 2007;147:573-7. Available from: http://
35. International Committee of Medical Journal Editors (ICMJE). Preparing for Submission. 2016 [cited 2017 June 07]. Available from: Available from: http://www.icmje.org/recommendations/browse/manuscriptpreparation/preparing-for-submission.html#d
36. The BMJ. Ethics approval of research. 2017 [cited 2017 June 07]. Available from: Available from: http://www.bmj.com/aboutbmj/resources-authors/formspolicies-andchecklists/ethics-approvalresearch
37. The JAMA Network. Instructions for Authors. 2017 [cited 2017 June 07]. Available from: Available from: http://jamanetwork.com/journals/jama/pages/instructions-for-authors
38. PLOS ONE. Submission Guidelines. 2017 [cited 2017 June 07]. Available from: Available from: http://journals.plos.org/plosone/s/submission-guidelines#loc-observationaland-field-studies
39. The Lancet. Instructions for Authors. 2017 [cited 2017 June 07]. Available from: Available from: http://www.thelancet.com/pb/assets/raw/Lancet/authors/lancet-information-forauthors.pdf
40. Springer. Publishing ethics. 2017 [cited 2017 June 07]. Available from: Available from: https://www.springer.com/gp/authorseditors/journal-author/journal-authorhelpdesk/publishing-ethics/14214
41. Committee on Publication Ethics (COPE). Ethics committee approval. 2015 [cited 2017 June 07]. Available from: Available from: https://publicationethics.org/case/ethicscommittee-approval
42. Committee on Publication Ethics (COPE). Seeking retrospective ethics approval. 2011 [cited 2017 June 07]. Available from: Available from: https://publicationethics.org/case/seeking-retrospective-ethics-approval